U.S. Department of Health and Human Services
NATIONAL INSTITUTES OF HEALTH NIH News
National Institute of Biomedical Imaging and Bioengineering (NIBIB) <http://www.nibib.nih.gov/>
For Immediate Release: Wednesday, November 3, 2021
CONTACTS: Raymond MacDougall, 301-496-3500, <e-mail:macdougallr@xxxxxxxxxxxx>
MEDIA ADVISORY
WHEN TO TEST OFFERS FREE ONLINE TOOL TO HELP INDIVIDUALS MAKE INFORMED COVID-19 TESTING DECISIONS
WHAT:
Demand is increasing for COVID-19 testing among individuals and families, especially as winter approaches and people shift to indoor activities. The National Institutes of Health's Rapid Acceleration of Diagnostics (RADx) initiative today announced the launch of the When To Test Calculator for Individuals, a companion to the version for organizations introduced last winter. By responding to just a few prompts, the new individual impact calculator indicates whether a person should get a test -- now or soon.
The When To Test Calculator for Individuals was developed and tested by computer modelers to help people determine if they are at risk of getting or transmitting COVID-19 based on just a few variables, such as vaccination status, transmission rates in the geographic area, and mitigation behaviors. The calculator includes answers to frequently asked questions and links both to resources on testing strategies and on obtaining supplies, including home tests.
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) supported development of the When To Test website, <https://whentotest.org>, and calculators through the RADx Tech program.
WHO:
NIBIB Director Bruce Tromberg, Ph.D., who leads the RADx Tech program, is available for comment.
About the Rapid Acceleration of Diagnostics (RADxSM) initiative: The RADx initiative was launched on April 29, 2020, to speed innovation in the development, commercialization, and implementation of technologies for COVID-19 testing. The initiative has four programs: RADx Tech, RADx Advanced Technology Platforms, RADx Underserved Populations and RADx Radical. It leverages the existing NIH Point-of-Care Technology Research Network. The RADx initiative partners with federal agencies, including the Office of the Assistant Secretary of Health, Department of Defense, the Biomedical Advanced Research and Development Authority, and U.S. Food and Drug Administration. Learn more about the RADx initiative and its programs: <https://www.nih.gov/radx>.
About the National Institute of Biomedical Imaging and Bioengineering (NIBIB): NIBIB's mission is to improve health by leading the development and accelerating the application of biomedical technologies. The Institute is committed to integrating the physical and engineering sciences with the life sciences to advance basic research and medical care. NIBIB supports emerging technology research and development within its internal laboratories and through grants, collaborations, and training. More information is available at the NIBIB website: <https://www.nibib.nih.gov>.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit <https://www.nih.gov>.
NIH...Turning Discovery into Health -- Registered, U.S. Patent and Trademark Office
###
This NIH News Release is available online at:
<https://www.nih.gov/news-events/news-releases/when-test-offers-free-online-tool-help-individuals-make-informed-covid-19-testing-decisions>
To subscribe (or unsubscribe) from NIH News Release mailings, go to
<http://service.govdelivery.com/service/subscribe.html?code=USNIH_1>.
If you subscribed via the NIH LISTSERV, go to <https://list.nih.gov/cgi-bin/wa.exe?A0=nihpress>.
